How can we slow the progression of atherosclerosis? Researcher Amanda Foks believes the answer may be switching off ageing immune cells. This could le...

A Dutch consortium has received €6.7 million to accelerate the development of nanomedicines together with patients. Researchers from Leiden University...

The Royal Holland Society of Sciences and Humanities (KHMW) has appointed four Leiden professors as members. Petra Sijpesteijn, Vanessa Mak, Mariska K...

At the EUFEPS Meeting in Vienna, Lianne Stevens and team received the EJPS – Best Paper Award 2024.

Anne van Rongen has been honoured with the Wayne A. Colburn Memorial Award at the 2024 Annual Meeting of the American College of Clinical Pharmacology...

Do you recall all those drugs that were hastily proposed as potential treatments for COVID-19? In the event of a future pandemic, the goal is to offer...

How do you detect people at high risk of heart attacks and strokes? And how can we improve the treatment of atherosclerosis? These are the questions t...

A memorable farewell symposium and a royal distinction: Professor Joke Bouwstra could not have completed her career at Leiden with more pleasure. On F...

One discovered that arteriosclerosis resembles an autoimmune disease, while the other developed a system to aid in the search for new medications. For...

PhD candidate Divakar Budda (Division of Systems Pharmacology and Pharmacy) and Solen Gousset (UCLouvain) shared were the shared winners of the best p...

Suruchi Nepal, postdoc in the group of Coen van Hasselt at LACDR, was awarded an NWO XS project which aims to study the response to antibiotic treatme...

'What nature made isn’t necessarily an optimized medicine to use in the human body,’ says Professor of Biological Chemistry Nathaniel Martin. That’s w...

The right medicine in the right dosage for every patient, that is something medical science aspires. 'Personalised medicine' is the term for that. But...

Two Leiden Science researchers received an NWO-XS grant for their research. Both projects are highly promising, but also high-risk. Macrophages that t...

In the Netherlands, 1.55 million people suffer from cardiovascular diseases. Yet, acute cardiovascular events, such as a heart attack or stroke, often...